Carregando empresa
Just reported
Q3 2026 results
From Teleflex's results release of 5 de novembro de 2026; its quarterly report has since been filed.
Revenue
Actual
US$ 567,8M
+0,1% y/y
-0,4% q/qGuided
—
No guide given
EPS, GAAP
Actual
US$ 22,28
Guided
—
No guide given
Operating income, GAAP
Actual
US$ 105,4M
+45% q/q
Guided
—
No guide given
Company outlook
Full year 2026
- EPS, adjustedUS$ 7,50 – US$ 7,75Raised +8,2%
- EPS, GAAPUS$ 2,84 – US$ 3,09Raised +10%
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →Keep exploring
The themes Teleflex is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Highest-graded in Medical Instruments and Supplies
Graded A or B and worth $2B or more: A first, then the largest.
ISRGIntuitive Surgical, Inc.US$ 152,5BA+
MDLNMedline Inc.US$ 52,6BA
ALCAlcon Inc.US$ 35BA
BLCOBausch & Lomb CorpUS$ 7,6BA-
ATRCAtriCure, Inc.US$ 2,9BA
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation21 de out. de 2026CBGraded C, now B
MCKMckesson Corporation4 de nov. de 2026BAGraded B, now A
CVSCVS Health Corp4 de nov. de 2026BAGraded B, now A
EWEdwards Lifesciences Corporation4 de nov. de 2026BAGraded B, now A
BIIBBiogen Inc.28 de out. de 2026BAGraded B, now A
Demonstrações financeiras completas →
Construído a partir dos próprios documentos de Teleflex Incorporated entregues à Comissão de Valores Mobiliários dos EUA (SEC). Os números são os divulgados, com o histórico por ação recalculado para a base de ações de hoje. Isto descreve um negócio — não é recomendação de investimento nem sugestão de compra ou venda.
